Trustworthy health information starts with knowing who's behind it. Here's our team, our review process, and our commitment to evidence-based accuracy.
Last updated November 18, 2026
Trustworthy health information depends on transparency — about who produces it, what sources it rests on, and how it is checked. This page explains exactly that. Regenerative Treatment Guide publishes patient education about stem cell and regenerative medicine for people exploring non-surgical options for knee, back, shoulder, hip, and joint pain. Below is who writes and reviews that content, the standards we hold it to, and how we handle the very real uncertainty in this field.
Our editorial team researches and writes plain-English explanations of regenerative medicine, drawing on peer-reviewed literature, clinical-trial registries, and regulatory guidance. We focus on helping patients understand non-surgical options — and on clearly separating established science from areas that are still investigational. We do not provide medical care, and nothing we publish is a substitute for a consultation with a licensed physician.
Dr. Long Vu, who goes by Dr. Long, is an osteopathic physician board-certified by the American Board of Anesthesiology in anesthesiology and in pain medicine. He earned his DO at the Chicago College of Osteopathic Medicine of Midwestern University in 2000 and completed his anesthesiology residency at Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital. He has practiced interventional pain medicine for more than 20 years, is licensed in Colorado and Florida, and now practices regenerative and longevity medicine at thriveMD in Centennial, Colorado. For Regenerative Treatment Guide, he reviews patient-education content for clinical accuracy, FDA-status language, and how risks and limitations are described.
Disclosure: Dr. Long practices at thriveMD, a clinic in our partner network that receives patient referrals through this site. He is not paid by Regenerative Treatment Guide for his reviews, and he may decline to approve any article. He does not review our Colorado page, our Approved Providers directory, or any content that names or compares thriveMD.
Verify: NPI 1194723973 · Florida license OS9477 · Colorado license DR.0057244 · ABA certification · Doximity
Review status: No articles carry Dr. Long's review yet. As he reviews each page, it will show a "Medically reviewed by" line with the date of his review. We never add a reviewer's name to a page he has not read. Our dog and veterinary content does not have a veterinary reviewer yet, and we are continuing to add reviewers.
A medical reviewer's job is not to rubber-stamp content. Before an article carries a "medically reviewed" label, the reviewer is asked to confirm that:
Not all sources are equal. When we research a topic, we prioritize evidence in roughly this order:
We do not treat clinic marketing material, testimonials, or anecdotal claims as evidence. When a topic is genuinely uncertain, we say so rather than overstating it.
Regenerative medicine is an area where marketing often runs ahead of the science, so we are deliberate about uncertainty. For example, the FDA states that stem cell and exosome products have not been approved for orthopedic uses, and that there are currently no approved exosome products. The approved stem cell products are cord-blood-derived, blood-forming cells for blood disorders and a few products for blood cancers and transplant complications, such as Ryoncil (December 2024). Regenerative products such as stem cells, exosomes, adipose-derived products, Wharton's jelly, cord blood, and amniotic fluid have not been approved to treat orthopedic conditions like osteoarthritis, tendonitis, disc disease, or back, hip, knee, neck, and shoulder pain. Where the research is promising but not conclusive — as with mesenchymal stem cells for knee osteoarthritis — we describe it as promising and investigational, not proven.
Medicine evolves, and so should our content. We review key articles periodically and update them when guidance, evidence, or regulatory status changes — noting the "last updated" date when we do. If you spot something you believe is inaccurate or out of date, we want to know. We investigate every good-faith report and correct confirmed errors promptly.
Questions, corrections, or concerns about anything we publish can be sent to [email protected]. Learn more about our methodology on the Our Approach to Research & Patient Guidance page.